Literature DB >> 9160338

Mutual modulation of sphingomyelinase and phospholipase A2 activities against mixed lipid monolayers by their lipid intermediates and glycosphingolipids.

M L Fanani1, B Maggio.   

Abstract

Sphingomyelinase activity against pure sphingomyelin monolayers is constant up to a surface pressure of 18 mN/m and falls above it. Sphingomyelinase- and phospholipase A2-mediated phosphohydrolytic pathways are mutually modulated by the presence of their respective substrates and products. At 15 mN/m non-substrate lipids such as ceramide at a mole fraction of 0.1 in mixed films with the pure substrate, inhibit the sphingomyelinase activity. Ganglioside GM1, another ceramide-containing complex sphingolipid, also inhibits sphingomyelinase activity, while a chemically related glycosphingolipid such as asialo-GM1 has no effect. The activity is unaltered by dipalmitoylphosphatidylcholine and by an equimolar mixture of its products of hydrolysis by phospholipase A2, fatty acid and lysoderivative, but it is inhibited by only one of them or by dilauroylphosphatidylcholine. Phospholipase A2 is inhibited by sphingomyelin, and activated by ceramide and by palmitic acid, one of the products of its own phosphohydrolytic reaction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9160338     DOI: 10.3109/09687689709048166

Source DB:  PubMed          Journal:  Mol Membr Biol        ISSN: 0968-7688            Impact factor:   2.857


  10 in total

Review 1.  Biochemical and structural information transduction at the mesoscopic level in biointerfaces containing sphingolipids.

Authors:  Bruno Maggio; Maria L Fanani; Rafael G Oliveira
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

2.  Coexistence of immiscible mixtures of palmitoylsphingomyelin and palmitoylceramide in monolayers and bilayers.

Authors:  Jon V Busto; María Laura Fanani; Luisina De Tullio; Jesús Sot; Bruno Maggio; Félix M Goñi; Alicia Alonso
Journal:  Biophys J       Date:  2009-11-18       Impact factor: 4.033

3.  Imaging the early stages of phospholipase C/sphingomyelinase activity on vesicles containing coexisting ordered-disordered and gel-fluid domains.

Authors:  Maitane Ibarguren; David J López; L-Ruth Montes; Jesús Sot; Adriana I Vasil; Michael L Vasil; Félix M Goñi; Alicia Alonso
Journal:  J Lipid Res       Date:  2011-01-20       Impact factor: 5.922

4.  Shape transitions and lattice structuring of ceramide-enriched domains generated by sphingomyelinase in lipid monolayers.

Authors:  Steffen Härtel; María Laura Fanani; Bruno Maggio
Journal:  Biophys J       Date:  2004-10-15       Impact factor: 4.033

5.  Surface pressure-dependent cross-modulation of sphingomyelinase and phospholipase A2 in monolayers.

Authors:  M L Fanani; B Maggio
Journal:  Lipids       Date:  1998-11       Impact factor: 1.880

6.  The 4,5-double bond of ceramide regulates its dipole potential, elastic properties, and packing behavior.

Authors:  Howard L Brockman; Maureen M Momsen; Rhoderick E Brown; Linli He; Jiong Chun; Hoe-Sup Byun; Robert Bittman
Journal:  Biophys J       Date:  2004-09       Impact factor: 4.033

7.  Bidirectional control of sphingomyelinase activity and surface topography in lipid monolayers.

Authors:  María Laura Fanani; Steffen Härtel; Rafael G Oliveira; Bruno Maggio
Journal:  Biophys J       Date:  2002-12       Impact factor: 4.033

8.  Sphingomyelinase-induced domain shape relaxation driven by out-of-equilibrium changes of composition.

Authors:  Maria Laura Fanani; Luisina De Tullio; Steffen Hartel; Jorge Jara; Bruno Maggio
Journal:  Biophys J       Date:  2009-01       Impact factor: 4.033

9.  Regulation of phosphatidic Acid metabolism by sphingolipids in the central nervous system.

Authors:  Susana J Pasquaré; Virginia L Gaveglio; Norma M Giusto
Journal:  J Lipids       Date:  2010-11-07

10.  ApoCIII-enriched LDL in type 2 diabetes displays altered lipid composition, increased susceptibility for sphingomyelinase, and increased binding to biglycan.

Authors:  Anne Hiukka; Marcus Ståhlman; Camilla Pettersson; Malin Levin; Martin Adiels; Susanne Teneberg; Eeva S Leinonen; Lillemor Mattsson Hultén; Olov Wiklund; Matej Oresic; Sven-Olof Olofsson; Marja-Riitta Taskinen; Kim Ekroos; Jan Borén
Journal:  Diabetes       Date:  2009-06-05       Impact factor: 9.461

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.